Trimethoprim is a potassium-sparing diuretic like amiloride and causes hyperkalemia in high-risk patients

American Journal of Therapeutics

Volumn 4, Issue 9-10, 1997, Pages 343-348

  Perazella, Mark A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse reactions; Amiloride; Hyperkalemia; Renal insufficiency; Trimethoprim sulfamethoxazole

Indexed keywords

AMILORIDE; POTASSIUM SPARING DIURETIC AGENT; TRIMETHOPRIM;

ARTICLE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MECHANISM; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; POTASSIUM EXCRETION; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030770192     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199709000-00010     Document Type: Article

References (27)

1. Lawson DH, Jick H: Adverse reactions to co-trimoxazole. Am J Med Sci 1978;275:53-57.
2. Jick H: Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982;4: 426-428.
3. Jawetz E: Sulfonamides and trimethoprim. In: Basic and Clinical Pharmacology, 2nd ed. (Ed. Katzung BG), Lange, Los Altos, CA 1984, pp 554-558.
4. Lawson DH, Paice BJ: Adverse reactions to trimethoprim-sulfamethoxazole. Rev Infect Dis 1982;4:429-433.
5. Richmond JM, Whitworth JA, Fairley KF, Kincaid-Smith P: Co-trimoxazole nephrotoxicity. Lancet 1979;1:493.
6. Cryst C, Hammar SP: Acute granulomatous interstitial nephritis due to co-trimoxazole. Am J Nephrol 1988;8: 483-488.
7. Velázquez H, Perazella MA, Wright FS, Ellison DH: Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 1993;119:296-301.
8. Choi MJ, Fernandez PC, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR: Trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med 1993; 328:703-706.
9. Greenberg S, Reiser IW, Chou SY, Porush JG: Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med 1993;119:291-295.
10. Perazella MA, Mahnensmith RL: Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose. Clin Nephrol 1996;46:187-192.
11. Kaufman AM, Hellman G, Abramson RG: Renal salt wasting and metabolic acidosis with trimethoprim-sulfamethoxazole therapy. Mt Sinai J Med 1983;50:238-239.
12. Medina I, Mills J, Leoung G, et al: Oral therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:776-782.
13. Funai N, Shimamoto Y, Matsuzaki M, et al: Hyperkalemia with renal tubular dysfunction by sulfamethoxazole-trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy. Haematologia 1993;25:137-141.
14. Canaday DH, Johnson JR: Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole. Ann Intern Med 1994;120:437-438.
15. Modest GA, Price B, Mascoli N: Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole. Ann Intern Med 1994;120:437.
16. Pennypacker LC, Mintzer J, Pitner J: Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole. Ann Intern Med 1994; 120:437.
17. Smith GW, Cohen SB: Hyperkalemia and non-oliguric renal failure associated with trimethoprim. Br Med J 1994;308:454.
18. Marinella MA: Reversible hyperkalemia associated with trimethoprim-sulfamethoxazole. Am J Med Sci 1995;310: 115-119.
19. Alappan R, Perazella MA, Buller GK: Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med 1996;124:316-320.
20. Sharpstone P: The renal handling of trimethoprim and sulfamethoxazole in man. Postgrad Med J 1969;45:38-42.
21. Schreiber M, Schlanger LE, Chen CB, et al: Antikaliuretic action of trimethoprim is minimized by raising urine pH. Kidney Int 1996;49:82-87.
22. Reiser IW, Chou S, Brown MI, Porush JG: Reversal of trimethoprim-induced antikaliuresis. Kidney Int 1996; 50:2063-2069.
23. Eiam-Ong S, Kurtzman NA, Sabatini S: Studies on the mechanism of trimethoprim-induced hyperkalemia. Kidney Int 1996;49:1372-1378.
24. Perazella MA: Hyperkalemia in the elderly: a group at high risk. Conn Med 1996;60:195-198.
25. Mulkerrin E, Epstein FH, Clarh BA: Aldosterone responses to hyperkalemia in healthy elderly humans. J Am Soc Nephrol 1995;6:1459-1462.
26. Kalin MF, Poretsky I, Seres DS, Zumoff B: Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med 1987;82:1035-1038.
27. Seney FD, Burns DK, Silva FG: Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 1990; 16:1-13.